Literature DB >> 26521730

Differential expression of interleukin-17 and interleukin-22 in inflamed and non-inflamed synovium from osteoarthritis patients.

C Deligne1, S Casulli2, A Pigenet1, C Bougault1, L Campillo-Gimenez2, G Nourissat3, F Berenbaum4, C Elbim2, X Houard1.   

Abstract

OBJECTIVE: Synovitis associated with osteoarthritis (OA) is directly responsible for several clinical symptoms and reflects OA's structural progression. This study sought to analyze the expression of proinflammatory mediations, including Interleukin (IL)-17 and IL-22, which play key roles in regulating inflammatory processes, in inflamed and non-inflamed areas of osteoarthritic synovium.
METHODS: Synovium from knees of 32 OA patients were collected at surgery. Macroscopic evaluation of inflammation enabled inflamed and non-inflamed areas to be separated. Samples were incubated to obtain tissue-conditioned media. Quantitative mRNA expression of proinflammatory mediators was analyzed by RT-PCR and protein levels by ELISA and gelatin zymography. Immunohistochemistry and histology were performed.
RESULTS: Inflamed synovium were characterized by increased leukocyte infiltration and a higher vessel-to-tissue area ratio than non-inflamed tissues. Macrophages, T and B lymphocytes, and some neutrophils were found only in the inflamed tissue, and only in the subintimal layer. Levels of proinflammatory cytokines and MMP-9 were significantly higher in tissue-conditioned media from inflamed than non-inflamed tissues. Inflamed areas were associated with higher expression of IL-17 and IL-22, both correlated with the combined release of IL-6, IL-23, and TGFβ1.
CONCLUSION: Our results showed that inflammatory cytokines, including IL-17 and IL-22, are expressed at higher levels by inflamed OA synovium and suggest IL-22 involvement in OA pathophysiology. This study will help identify new therapeutic strategies for OA, especially the targeting of IL-22 to decrease inflammation.
Copyright © 2014. Published by Elsevier Ltd.

Entities:  

Keywords:  IL-17; IL-22; Osteoarthritis; Synovial inflammation

Mesh:

Substances:

Year:  2015        PMID: 26521730     DOI: 10.1016/j.joca.2014.12.007

Source DB:  PubMed          Journal:  Osteoarthritis Cartilage        ISSN: 1063-4584            Impact factor:   6.576


  23 in total

1.  Identification of differentially expressed genes in synovial tissue of osteoarthritis based on a more robust integrative analysis method.

Authors:  Haitao Chen; Qubo Ni; Bin Li; Liaobin Chen
Journal:  Clin Rheumatol       Date:  2021-03-06       Impact factor: 2.980

2.  Thirty days after anterior cruciate ligament transection is sufficient to induce signs of knee osteoarthritis in rats: pain, functional impairment, and synovial inflammation.

Authors:  Germanna M Barbosa; Jonathan E Cunha; Thiago L Russo; Thiago M Cunha; Paula A T S Castro; Francisco F B Oliveira; Fernando Q Cunha; Fernando S Ramalho; Tania F Salvini
Journal:  Inflamm Res       Date:  2020-01-31       Impact factor: 4.575

3.  Interleukin-17A Causes Osteoarthritis-Like Transcriptional Changes in Human Osteoarthritis-Derived Chondrocytes and Synovial Fibroblasts In Vitro.

Authors:  Jolet Y Mimpen; Mathew J Baldwin; Adam P Cribbs; Martin Philpott; Andrew J Carr; Stephanie G Dakin; Sarah J B Snelling
Journal:  Front Immunol       Date:  2021-05-12       Impact factor: 7.561

Review 4.  [The role of helper T cell in the pathogenesis of osteoarthritis].

Authors:  Dinglong Yang; Zhiqiang Zhang
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2020-07-15

5.  IL-6 secretion in osteoarthritis patients is mediated by chondrocyte-synovial fibroblast cross-talk and is enhanced by obesity.

Authors:  Mark J Pearson; Dietmar Herndler-Brandstetter; Mohammad A Tariq; Thomas A Nicholson; Ashleigh M Philp; Hannah L Smith; Edward T Davis; Simon W Jones; Janet M Lord
Journal:  Sci Rep       Date:  2017-06-14       Impact factor: 4.379

6.  Presence of IL-17 in synovial fluid identifies a potential inflammatory osteoarthritic phenotype.

Authors:  Sarah J B Snelling; Sylvette Bas; Gabor J Puskas; Stephanie G Dakin; Domizio Suva; Axel Finckh; Cem Gabay; Pierre Hoffmeyer; Andrew J Carr; Anne Lübbeke
Journal:  PLoS One       Date:  2017-04-11       Impact factor: 3.240

Review 7.  Synovitis in osteoarthritis: current understanding with therapeutic implications.

Authors:  Alexander Mathiessen; Philip G Conaghan
Journal:  Arthritis Res Ther       Date:  2017-02-02       Impact factor: 5.156

8.  Plasma miR-136 can be used to screen patients with knee osteoarthritis from healthy controls by targeting IL-17.

Authors:  Lei Wan; Qiang Zhao; Gang Niu; Tai Xiang; Cuilei Ding; Shijie Wang
Journal:  Exp Ther Med       Date:  2018-08-20       Impact factor: 2.447

9.  Immunological Events, Emerging Pharmaceutical Treatments and Therapeutic Potential of Balneotherapy on Osteoarthritis.

Authors:  Anna Scanu; Lucrezia Tognolo; Maria Chiara Maccarone; Stefano Masiero
Journal:  Front Pharmacol       Date:  2021-06-30       Impact factor: 5.810

10.  Identification of genes and pathways in the synovia of women with osteoarthritis by bioinformatics analysis.

Authors:  Bobin Mi; Guohui Liu; Wu Zhou; Huijuan Lv; Yi Liu; Jing Liu
Journal:  Mol Med Rep       Date:  2018-01-15       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.